Author:
Aghevlian Sadaf,Wu Bo,Raie Marina Nura,Tumbale Spencer K.,Kare Aris J.,Seo Jai W.,Ferrara Katherine W.
Funder
National Institutes of Health
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine
Reference47 articles.
1. Concepts for agonistic targeting of CD40 in immuno-oncology;Richards;Hum Vaccin Immunother,2020
2. Copy number of the X-linked genes TLR7 and CD40L influences innate and adaptive immune responses;Sarmiento;Scand J Immunol,2019
3. A CD40 agonist potentiates the efficacy and immune-stimulatory capacity of chemotherapy in combination with a focal adhesion kinase inhibitor in a mouse model of pancreatic ductal adenocarcinoma;Stone;Cancer Res,2019
4. CD40 agonist antibodies in cancer immunotherapy;Vonderheide;Annu Rev Med,2020
5. Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity;Knorr;Proc Natl Acad Sci U S A,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Organ dose assessment in nuclear medicine practice in Indonesia: A review;CHEMISTRY BEYOND BORDERS: INTERNATIONAL CONFERENCE ON PHYSICAL CHEMISTRY: The 1st Annual Meeting of the Physical Chemistry Division of the Indonesian Chemical Society;2023
2. Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer;Theranostics;2022